Survival of dental implants and occurrence of osteoradionecrosis in irradiated head and neck cancer patients: a systematic review and meta-analysis
DJ Toneatti, RR Graf, JP Burkhard, B Schaller - Clinical oral investigations, 2021 - Springer
Objectives This systematic review assesses dental implant survival, calculates the incidence
rate of osteoradionecrosis, and evaluates risk factors in irradiated head and neck cancer …
rate of osteoradionecrosis, and evaluates risk factors in irradiated head and neck cancer …
The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana‐Farber/Brigham and Women's Cancer Center …
Background Osteoradionecrosis of the jaw (ORN) is an infrequent yet potentially devastating
complication of radiation therapy to the head and neck region. Treatment options include …
complication of radiation therapy to the head and neck region. Treatment options include …
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomized controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the …
RJ Shaw, CJ Butterworth, P Silcocks, BT Tesfaye… - International Journal of …, 2019 - Elsevier
Purpose Hyperbaric oxygen (HBO) has been advocated in the prevention and treatment of
osteoradionecrosis (ORN) of the jaw after head and neck radiation therapy, but supporting …
osteoradionecrosis (ORN) of the jaw after head and neck radiation therapy, but supporting …
Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial …
AA Owosho, CL Estilo, JM Huryn, SHK Yom - Oral surgery, oral medicine …, 2016 - Elsevier
Objective Very few studies have evaluated the efficacy of pentoxifylline and tocopherol
(PENT-E) in the management of medication-related osteonecrosis of the jaw (MRONJ) …
(PENT-E) in the management of medication-related osteonecrosis of the jaw (MRONJ) …
The dental management of patients irradiated for head and neck cancer
Patients undergoing radiotherapy for head and neck cancers are prone to a range of dental
complications, including mucositis, trismus, xerostomia, radiation caries and …
complications, including mucositis, trismus, xerostomia, radiation caries and …
Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review
M Martos-Fernández, M Saez-Barba… - Oral surgery, oral …, 2018 - Elsevier
Objective The purpose of this study was to evaluate the healing benefit provided by the
antioxidant and antifibrotic properties of pentoxifylline–tocopherol or pentoxifylline …
antioxidant and antifibrotic properties of pentoxifylline–tocopherol or pentoxifylline …
Prevention and management of osteoradionecrosis in patients with head and neck cancer treated with radiation therapy: ISOO-MASCC-ASCO guideline
DE Peterson, SA Koyfman, N Yarom… - Journal of Clinical …, 2024 - ascopubs.org
ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …
the relevant literature for each recommendation, following the guideline development …
Radiation-induced tissue damage: clinical consequences and current treatment options
H Nepon, T Safran, EM Reece… - Seminars in Plastic …, 2021 - thieme-connect.com
Radiation therapy is a valuable tool in the treatment of numerous malignancies but, in
certain cases, can also causes significant acute and chronic damage to noncancerous …
certain cases, can also causes significant acute and chronic damage to noncancerous …
How we manage medication-related osteonecrosis of the jaw
Bone-modifying agents (BMAs) are integral to managing patients with advanced cancer.
They improve quality of survival by reducing skeletal-related events, treating …
They improve quality of survival by reducing skeletal-related events, treating …
Modern management of osteoradionecrosis
BS Raggio, R Winters - Current opinion in otolaryngology & head …, 2018 - journals.lww.com
The fibroatrophic process has gained acceptance as a main mechanism of ORN. No gold
standard treatment or consensus guidelines exist, though a combination of therapeutic …
standard treatment or consensus guidelines exist, though a combination of therapeutic …